|
|
Article: Omnaris nasal spray.(New & Approved)(Drug overview)
- Article from:
- Family Practice News
- Article date:
- February 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Omnaris Nasal Spray (ciclesonide nasal spray, Nycomed) The FDA approved Omnaris (ciclesonide) Nasal Spray for treatment of seasonal allergic rhinitis in patients aged 6-11 years.
* Recommended Dosage: The recommended 200 mcg per day is delivered as two sprays (50 mcg per spray) in each nostril once daily for treatment of seasonal allergic rhinitis in adults and children 6 years of age and older.
* Special Considerations: Headache, nasopharyngitis, and pharyngolaryngeal pain were the most common adverse events associated with Omnaris Nasal Spray in a study of patients aged 6-11 years.
Patients who are on immunosuppressive doses of corticosteroids ...